Get my own profile
Public access
View all16 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Silvia BuonamiciConsultant Third Rock VenturesVerified email at thirdrockventures.com
- Shridar GanesanProfessor of Medicine, Rutgers Cancer Institute of New JerseyVerified email at cinj.rutgers.edu
- Anant Akash AgrawalRemix TherapeuticsVerified email at remixtx.com
- Anupama ReddyData Scientist | Co-founder @ Vindhya Data ScienceVerified email at vindhyadatascience.com
- James PalacinoHead of Biology, Orum TherapeuticsVerified email at orumrx.com
- Benjamin L. EbertDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
- Frederic VaillancourtSVP, Head of Early Research, Remix TherapeuticsVerified email at remixtx.com
- Peter Fekkes54gene, HotSpot Therapeutics, H3 Biomedicine, Novartis, UC San Diego, University of GroningenVerified email at 54gene.com
- George VassiliouProfessor of Haematological Medicine, University of Cambridge & Cambridge Stem Cell InstituteVerified email at sanger.ac.uk
- Annalisa MupoScientific Programme ManagerVerified email at altoslabs.com
- Chia-Ling HuangNovartis Institutes of Biomedical ResearchVerified email at bu.edu
- Peter SmithUniversity of SunderlandVerified email at sunderland.ac.uk
- Zuzana TothovaDana-Farber Cancer Institute, Broad InstituteVerified email at broadinstitute.org
- Jinesh GheeyaThe Ohio State UniversityVerified email at osumc.edu
- Katsuhiro TogamiMedical oncology, Dana-Farbar Cancer InstitutionVerified email at dfci.harvard.edu
- Andrew A. Lane, MD, PhDDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
- Stanley Chun-Wei LeeFred Hutchinson Cancer CenterVerified email at fredhutch.org
- Bryan M. DunyakRemix TherapeuticsVerified email at remixtx.com
- Jesper L.V. MaagRemix TherapeuticsVerified email at remixtx.com